(Q48668802)

14 February 2018

title

Hypothalamic-pituitary-adrenocortical activity in panic disorder: Relationship to plasma catecholamine metabolites (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

22 October 2022

1 reference

G. N. Gurguis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657223

22 October 2022

I. N. Mefford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657223

22 October 2022

T. W. Uhde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657223

22 October 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

14 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:000632239190312A?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

https://api.elsevier.com/content/article/PII:000632239190312A?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

22 October 2022

published in

Biological Psychiatry

1 reference

14 February 2018

volume

30

1 reference

14 February 2018

page(s)

502-506

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Dexamethasone suppression test in patients with panic attacks.

22 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Endocrine and physiological changes during "spontaneous" panic attacks

22 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Rapid and simple determination of homovanillic acid in plasma using high performance liquid chromatography with electrochemical detection

22 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Anxiety and plasma cortisol at the crest of the circadian cycle:reappraisal of a classical hypothesis

22 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Plasma MHPG in untreated panic disorder.

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Neurotransmitters and pituitary function: regulation of ACTH secretion

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

The hypothalamic-pituitary-adrenal system in panic disorder

22 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia.

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Possible mechanisms for lactate's induction of panic

22 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Catecholamine metabolism and disposition in healthy and depressed subjects

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline.

22 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Adrenergic function in patients with panic anxiety

22 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

The dexamethasone suppression test in agoraphobia.

22 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.

22 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Central epinergic inhibition of corticosterone release in rat

22 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

22 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Plasma HVA and anxiety in patients with panic disorder.

22 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection

22 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.

22 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

Substances modulating the secretion of ACTH by cultured anterior pituitary cells

22 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90312-A

22 October 2022

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018